Dyne Therapeutics, Inc. (DYN)
18.52
+0.31
(+1.70%)
USD |
NASDAQ |
Sep 14, 16:00
18.52
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Price to Book Value : 4.370 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 14, 2026 | 4.370 |
| September 11, 2026 | 4.297 |
| September 10, 2026 | 4.346 |
| September 09, 2026 | 4.528 |
| September 08, 2026 | 4.792 |
| September 04, 2026 | 5.729 |
| September 03, 2026 | 5.887 |
| September 02, 2026 | 5.932 |
| September 01, 2026 | 5.922 |
| August 31, 2026 | 6.000 |
| August 28, 2026 | 5.915 |
| August 27, 2026 | 6.156 |
| August 26, 2026 | 6.220 |
| August 25, 2026 | 6.215 |
| August 24, 2026 | 6.132 |
| August 21, 2026 | 6.158 |
| August 20, 2026 | 6.130 |
| August 19, 2026 | 6.319 |
| August 18, 2026 | 6.135 |
| August 17, 2026 | 6.17 |
| August 14, 2026 | 6.064 |
| August 13, 2026 | 6.125 |
| August 12, 2026 | 6.175 |
| August 11, 2026 | 6.302 |
| August 10, 2026 | 6.253 |
| Date | Value |
|---|---|
| August 07, 2026 | 6.194 |
| August 06, 2026 | 6.106 |
| August 05, 2026 | 6.175 |
| August 04, 2026 | 6.128 |
| August 03, 2026 | 5.955 |
| July 31, 2026 | 5.941 |
| July 30, 2026 | 6.071 |
| July 29, 2026 | 5.922 |
| July 28, 2026 | 6.111 |
| July 27, 2026 | 6.047 |
| July 24, 2026 | 5.767 |
| July 23, 2026 | 5.637 |
| July 22, 2026 | 5.476 |
| July 21, 2026 | 5.623 |
| July 20, 2026 | 5.533 |
| July 17, 2026 | 5.601 |
| July 16, 2026 | 5.361 |
| July 15, 2026 | 5.660 |
| July 14, 2026 | 5.611 |
| July 13, 2026 | 5.578 |
| July 10, 2026 | 5.526 |
| July 09, 2026 | 5.726 |
| July 08, 2026 | 5.623 |
| July 07, 2026 | 5.623 |
| July 06, 2026 | 5.389 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sarepta Therapeutics, Inc. | 1.446 |
| Neurocrine Biosciences, Inc. | 4.325 |
| Recursion Pharmaceuticals, Inc. | 1.990 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.65 |
Price to Book Value Related Metrics
| Price | 18.52 |
| Earnings Yield | -17.99% |
| Market Cap | 3.068B |